Sort
40,608 grants matching “prostate cancer”
THE ROLE OF CRIPTO SIGNALING IN LETHAL PROSTATE CANCER
$822,356Universitat Bern · · FY2019 · Department of the Army
A NOVEL SMALL MOLECULE CX3CR1 ANTAGONIST HALTS METASTASIS
$822,075Joseph M Salvino · Alliance Discovery, Inc. · R44 · FY2017 · CA
PHASE III TRIAL OF SELENIUM FOR PROSTATE CANCER PREVENT
$822,021University Of Arizona · R01 · FY2002 · CA
Pathomic Predictors of Prostate Cancer Progression
$821,911Parag Kumar Mallick · Stanford University · R01 · FY2022 · CA
A PHASE 2 TRIAL OF COMBINED LUTETIUM PSMA THERANOSTICS AND DOCETAXEL IN NEWLY DIAGNOSED METASTATIC HORMONE NAIVE PROSTATE CANCER
$821,790University Of Melbourne · · FY2019 · Department of the Army
SELENIUM BASED CHEMOPREVENTION
$821,563Cancer Therapy And Research Center · U01 · FY2003 · CA
A high sensitivity gamma camera using a combination of Compton reconstruction and source proximity for in-vivo imaging of Ac-225
$821,522Javier Caravaca · University Of California, San Francisco · R01 · FY2022 · EB
Developmental Funds
$821,254Howard H Bailey · University Of Wisconsin-Madison · P30 · FY2018 · CA
ARKANSAS SPECIAL POPULATIONS ACCESS NETWORK (A-SPAN)
$820,491University Of Arkansas Med Scis Ltl Rock · U01 · FY2002 · CA
3/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
$820,069Mariana C Stern · University Of Southern California · U54 · FY2024 · CA
Northwest Community Clinical Oncology Program
$819,526Tacoma General Hospital · U10 · FY2003 · CA
Minority Based Community Clinical Oncology Program
$819,197David J Peace · University Of Illinois At Chicago · U10 · FY2009 · CA
THERAPEUTIC TARGETING OF A MASTER REGULATOR OF ANDROGEN RECEPTOR-INDIFFERENT PROSTATE CANCER
$819,100Cedars-Sinai Medical Center · · FY2019 · Department of the Army
Molecular, Cellular, and Tissue Characterization Unit
$819,068Joe W. Gray · Oregon Health & Science University · U2C · FY2018 · CA
INTEGRATED ULTRASONIC SYSTEMS FOR NONINVASIVE THERAPY
$818,987Riverside Research Institute · R01 · FY2001 · CA
Development of a novel class of immunotherapeutic antibody for metastatic prostate cancer
$818,940Grant H Risdon · Cancure, Llc · R44 · FY2019 · CA
MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM
$818,903Mount Sinai Medical Center (Miami Beach) · U10 · FY2004 · CA
Light scattering and normal tissue models
$818,518University Of Calif-Los Alamos Nat Lab · R01 · FY2001 · CA
P3IK Signaling and Biology of Therapeutic Response in Brain and Prostate Tumors
$818,272Eric C Holland · Sloan-Kettering Inst Can Research · U01 · FY2012 · CA
Enabling Technologies for MRI-Guided Prostate Interventions
$818,115Clare M Tempany · Brigham And Women'S Hospital · R01 · FY2011 · CA
Time Domian Electron Paramagnetic Resonance Imaging
$817,876Murali Cherukuri · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
NEXT-GENERATION HUMAN PROSTATE CANCER COCULTURES TO OPTIMIZE AUTOLOGOUS CHIMERIC ANTIGEN RECEPTOR T-CELL IMMUNOTHERAPY
$817,785Fred Hutchinson Cancer Research Center · · FY2019 · Defense Health Agency
GENETIC EPIDEMIOLOGY OF PROSTATE CANCER
$817,584Stanford University · U01 · FY2000 · CA
IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells
$817,442Albert Sidney Baldwin · Univ Of North Carolina Chapel Hill · R35 · FY2019 · CA
PRIMARY PRODUCT/SERVICE CODE TO: B537, DESCRIPTION: CENTRAL DATA COLLECTION CENTER (CDCC), WESTAT
$817,270Sunitha Mathew · Westat, Inc. · N01 · FY2020 · CA